Clinical Trial Update: A Clinical Study to Investigate the Effect of an Investigational Drug as an Added Medication to an Antipsychotic, in Adults With Schizophrenia, as Measured Positron Emission Tomography (PET) Imaging [Phase 1]

View source ↗

Summary

Phase 1 study evaluating an investigational drug added to an antipsychotic in adults with schizophrenia, using PET imaging to assess effects. The trial has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Investigational drug (add-on to antipsychotic)
• Unspecified antipsychotic

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED | Results posted: 2024-11-25